Walleye Trading
ANIK icon

Walleye Trading’s Anika Therapeutics ANIK Stock Holding History

Walleye Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,922
Closed -$201K – 5110
2021
Q1 		$201K Buy
4,922
+4,097
+497% +$155K ﹤0.01% 3603
2020
Q4 		$37K Sell
825
-4,296
-84% -$163K ﹤0.01% 4277
2020
Q3 		$181K Buy
5,121
+4,767
+1,347% +$172K ﹤0.01% 3058
2020
Q2 		$13K Sell
354
-6,709
-95% -$221K ﹤0.01% 4032
2020
Q1 		$204K Buy
7,063
+6,121
+650% +$248K ﹤0.01% 2582
2019
Q4 		$49K Buy
+942
New +$54.7K ﹤0.01% 3803
2019
Q3 		– Sell
-5,873
Closed -$302K – 3989
2019
Q2 		$239K Buy
+5,873
New +$214K ﹤0.01% 2806
2018
Q4 		– Sell
-1,019
Closed -$43K – 4581
2018
Q3 		$43K Sell
1,019
-10,189
-91% -$403K ﹤0.01% 4604
2018
Q2 		$359K Buy
+11,208
New +$462K ﹤0.01% 3131
2016
Q1 		– Sell
-2,000
Closed -$76K – 5288
2015
Q4 		$76K Buy
+2,000
New +$76.5K ﹤0.01% 3526

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Walleye Trading's ANIK Position: Q2 2021 in Review

Walleye Trading sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 4,922 shares — an estimated $201K sold.

Walleye Trading first reported a position in ANIK in Q4 2015 and held it in 10 quarters. The position peaked at $359K in Q2 2018. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

  • Walleye Trading reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 4,922 Anika Therapeutics shares in Q2 2021, an estimated $201K.
  • Walleye Trading first reported a position in Anika Therapeutics in Q4 2015 and held it in 10 quarters.
  • Walleye Trading's Anika Therapeutics position peaked at $359K in Q2 2018.
  • 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.